TaiGen Biopharmaceuticals Holdings Ltd (ROCO:4157)
NT$ 14.4 -0.25 (-1.71%) Market Cap: 10.34 Bil Enterprise Value: 9.30 Bil PE Ratio: 43.76 PB Ratio: 8.83 GF Score: 74/100